Compugen Ltd at JMP Securities Life Sciences Conference Transcript
(audio in progress) JMP Securities Life Sciences Conference. It's my pleasure to introduce Compugen. Presenting for the company is Ari Krashin.
And I'm Ren Benjamin. I'm one of those senior analysts here in the biotech division. And Compugen is one of the companies that we cover. And a lot of our coverage has to do with oncology. And Compugen really, in our view, exemplifies some of our coverage universe.
And so here to tell us more, Ari, take this away.
Thank you very much, Reni. Good morning. Thank you for having us in this conference. My name is Ari Krashin. I am the CFO and COO. With me, my colleague, Dr. Henry Adewoye, the CMO.
Okay. So Compugen, we are a clinical-stage cancer immunotherapy company, pioneers in computation on target discovery.
Now when you come to think about it, the thing I like about Compugen, among others obviously, and when we come to present year after year in conferences such as this one and others, it's never
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
